Results 261 to 270 of about 12,522,600 (400)

The exosomal protein biomarkers auxiliary in diagnosis of interstitial lung disease. [PDF]

Respir Res
Dong M, Hu G, Chen X, Zhang L, Zhang Y, Fang Y, Liao S, Wang Y, Li Q, Zheng P, Guo B, Lai T, Luo Q, Huang H, Han Q, Sun B.   +15 more
europepmc   +1 more source

Cytokine, Chemokine, and Neurofilament Light Chain Signatures in LGI1 Autoimmune Encephalitis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives To investigate the value of cytokine, chemokine, and neurofilament light chain (NfL) concentrations in predicting relapse risk, chronic epilepsy, and functional impairment in LGI1 autoimmune encephalitis (AE). Methods Cytokines/chemokines (IL‐1‐beta, IL‐2, IL‐4, IL‐5, IL‐6, IL‐8/CXCL8, IL‐10, IL‐12p70, IL‐13, IL‐17A, GM‐CSF, TNF ...
Albert Aboseif, Georgios Mangioris, Binxia Yang, Vanessa K. Pazdernik, Jeffrey W. Britton, Divyanshu Dubey, Eoin P. Flanagan, Sarosh R. Irani, Gregory S. Day, Charles L. Howe, A. Sebastian López‐Chiriboga, Andrew McKeon, John R. Mills, Yahel Segal, Michel Toledano, Ivana Vodopivec, Sean J. Pittock, Anastasia Zekeridou   +17 more
wiley   +1 more source

Occupational Lung Disease

Canadian Journal of Respiratory, Critical Care, and Sleep Medicine, 2012
openaire   +3 more sources

Telomere Shortening in Interstitial Lung Disease: Challenges and Promises. [PDF]

Clin Respir J
Jin H, Song J, Gao R, Sha B, Wang S, Luo P, Yu L, Xu X, Wang X.   +8 more
europepmc   +1 more source

Serum enzymes in disease. XI. Glycolytic and oxidative enzymes and transaminases in patients with cancer of the lung [PDF]

, 1962
Michael West, Maurice A. Schwartz, William S. Walsh, Hyman J. Zimmerman   +3 more
openalex   +1 more source

Assessing a Mitochondrial Disease Treatment via a Novel Statistical Technique for Accelerometer Data

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Therapeutic development for mitochondrial diseases, rare genetic disorders with pathogenic defects of oxidative phosphorylation, is hindered by unsatisfactory outcome measures. To address this problem, we provide the first clinical application of a novel, bias‐adjusted outcome measure of acceleration across a range of subjects ...
Ian W. McKeague, Kristin Engelstad, Yue Ge, Amber Tucker, Shufang Li, Jasim Uddin, Ziwei Zhao, John L. P. Thompson, Michio Hirano   +8 more
wiley   +1 more source

Complexity of interstitial lung disease disproportionality signal analysis in pharmacovigilance databases. [PDF]

EClinicalMedicine
Freppel R, Hlavaty A, Bari I, Khouri C, Grandvuillemin A.   +4 more
europepmc   +1 more source

Restrictive Lung Disease [PDF]

, 1968
Warren M. Gold
openalex   +1 more source

Development of a personalized visualization and analysis tool to improve clinical care in complex multisystem diseases with application to scleroderma

Arthritis Care &Research, Accepted Article.
Background In complex diseases, it is challenging to assess a patient's disease state, trajectory, treatment exposures, and risk of multiple outcomes simultaneously, efficiently and at the point of care. Methods We developed an interactive patient‐level data visualization and analysis tool (VAT) that automates illustration of a scleroderma patient's ...
Ji Soo Kim, John Scott, Lauren Fisher, Lauren N. Smith, Willie Stewart, Adrianne Woods, Rob Smithwright, Diane Koher, Parastoo Aslanbeik, Aalok B. Shah, Brad Tibbils, Samantha I. Pitts, Ayse P. Gurses, Yushi Yang, Ana‐Maria Orbai, Antony Rosen, Laura K. Hummers, Scott L. Zeger, Ami A. Shah   +18 more
wiley   +1 more source

The lung microbiome in interstitial lung disease. [PDF]

Breathe (Sheff)
Mikhail SG, O'Dwyer DN.
europepmc   +1 more source